Your browser doesn't support javascript.
loading
Cardiovascular phenotype of mice lacking 3-mercaptopyruvate sulfurtransferase.
Peleli, Maria; Bibli, Sofia-Iris; Li, Zhen; Chatzianastasiou, Athanasia; Varela, Aimilia; Katsouda, Antonia; Zukunft, Sven; Bucci, Mariarosaria; Vellecco, Valentina; Davos, Constantinos H; Nagahara, Noriyuki; Cirino, Giuseppe; Fleming, Ingrid; Lefer, David J; Papapetropoulos, Andreas.
Afiliação
  • Peleli M; Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece.
  • Bibli SI; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, German Centre for Cardiovascular Research (DZHK) Partner Site Rhein-Main, Frankfurt am Main, Germany.
  • Li Z; Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
  • Chatzianastasiou A; "George P. Livanos and Marianthi Simou" Laboratories, First Department of Pulmonary and Critical Care Medicine, Evangelismos Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Varela A; Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece.
  • Katsouda A; Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece.
  • Zukunft S; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, German Centre for Cardiovascular Research (DZHK) Partner Site Rhein-Main, Frankfurt am Main, Germany.
  • Bucci M; Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy.
  • Vellecco V; Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy.
  • Davos CH; Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece.
  • Nagahara N; Isotope Research Center, Nippon Medical School, Tokyo, Japan.
  • Cirino G; Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy.
  • Fleming I; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, German Centre for Cardiovascular Research (DZHK) Partner Site Rhein-Main, Frankfurt am Main, Germany.
  • Lefer DJ; Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
  • Papapetropoulos A; Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece. Electronic address: apapapet@pharm.uoa.gr.
Biochem Pharmacol ; 176: 113833, 2020 06.
Article em En | MEDLINE | ID: mdl-32027885
ABSTRACT
RATIONALE Hydrogen sulfide (H2S) is a physiological mediator that regulates cardiovascular homeostasis. Three major enzymes contribute to the generation of endogenously produced H2S, namely cystathionine γ-lyase (CSE), cystathionine ß-synthase (CBS) and 3-mercaptopyruvate sulfurtransferase (3-MST). Although the biological roles of CSE and CBS have been extensively investigated in the cardiovascular system, very little is known about that of 3-MST. In the present study we determined the importance of 3-MST in the heart and blood vessels, using a genetic model with a global 3-MST deletion.

RESULTS:

3-MST is the most abundant transcript in the mouse heart, compared to CSE and CBS. 3-MST was mainly localized in smooth muscle cells and cardiomyocytes, where it was present in both the mitochondria and the cytosol. Levels of serum and cardiac H2S species were not altered in adult young (2-3 months old) 3-MST-/- mice compared to WT animals. No significant changes in the expression of CSE and CBS were observed. Additionally, 3-MST-/- mice had normal left ventricular structure and function, blood pressure and vascular reactivity. Interestingly, genetic ablation of 3-MST protected mice against myocardial ischemia reperfusion injury, and abolished the protection offered by ischemic pre- and post-conditioning. 3-MST-/- mice showed lower expression levels of thiosulfate sulfurtransferase, lower levels of cellular antioxidants and elevated basal levels of cardiac reactive oxygen species. In parallel, 3-MST-/- mice showed no significant alterations in endothelial NO synthase or downstream targets. Finally, in a separate cohort of older 3-MST-/- mice (18 months old), a hypertensive phenotype associated with cardiac hypertrophy and NO insufficiency was observed.

CONCLUSIONS:

Overall, genetic ablation of 3-MST impacts on the mouse cardiovascular system in an age-dependent manner. Loss of 3-MST exerts a cardioprotective role in young adult mice, while with aging it predisposes them to hypertension and cardiac hypertrophy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfurtransferases / Sistema Cardiovascular / Miócitos Cardíacos / Sulfeto de Hidrogênio Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfurtransferases / Sistema Cardiovascular / Miócitos Cardíacos / Sulfeto de Hidrogênio Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article